$876.57 Million in Sales Expected for Alexion Pharmaceuticals, Inc. (ALXN) This Quarter


Equities research analysts expect that Alexion Pharmaceuticals, Inc. will announce $876.57 million in sales for the current fiscal quarter, according to Zacks . Nine analysts have issued estimates for Alexion Pharmaceuticals' earnings, with estimates ranging from $847.72 million to $900.89 million.



from Biotech News